Background
Treatment
Our Products
Symposia & Congresses
Studies & Publications
News Centre
Links
Boehringer Ingelheim stroke website
Background
Stroke / TIA facts
Stroke Morbidity and Morality
Cost of Stroke
Prevalence / Incidence
Pathogenesis / Pathophysiology
Stroke Subtypes
Pathogenesis of Ischaemic Stroke
Pathogenic Process of Ischaemic Stroke
Symptoms & Diagnostic Procedures
Transient Ischaemic Attack (TIA) & Stroke
Diagnostic Procedures
Risk Factors
Treatment
Guidelines
Acute Treatment Guidelines
Secondary Prevention Guidelines
References to Guidelines
Acute Treatment
Emergency Medical Service
General Stroke Therapy
Acute Antithrombotic Treatment
Thrombolytic Therapy
Secondary Complications
Secondary Stroke Prevention
Aspirin and Dipyridamole
Clopidogrel in the Secondary Prevention
Our Products
Actilyse®
Aggrenox®
Symposia & Congresses
Calender
Virtual Symposia
Events
Topics
Speakers
Associations
Studies & Publications
Acute Treatment
Publications
Streptokinase Studies
ATLANTIS
NINDS
ECASS 1
ECASS 2
ECASS 3
Combined Analysis
PROACT II
SITS-MOST
CASES
Secondary Prevention
PRoFESS
ONTARGET / TRANSCEND
ESPS I
ESPS II
ESPS II Reanalysis
ESPRIT
CARDIAC SAFETY
MATCH
Bioavailability
Cost-Effectiveness
Metaanalysis
Combined Analysis
News Centre
Links
General Background
Guidelines
Journals
Search
Contact
© 2005 Boehringer Ingelheim GmbH, Germany. All rights reserved.
Imprint
|
Terms of use
Search
Site Map
Contact